230 related articles for article (PubMed ID: 22678019)
1. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
Reck M; Rosell R; Tiemann M
Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
[No Abstract] [Full Text] [Related]
2. [Quality assurance].
Flentje M; Hoffmann H; Huber RM
Onkologie; 2012; 35 Suppl 3():14-6. PubMed ID: 22678020
[No Abstract] [Full Text] [Related]
3. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
Lennes IT; Lynch TJ
Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
[TBL] [Abstract][Full Text] [Related]
4. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
[TBL] [Abstract][Full Text] [Related]
5. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
[No Abstract] [Full Text] [Related]
6. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)].
Baumann M; Dienemann HC; Fietkau R; Rübe C; Thomas M
Onkologie; 2006 Sep; 29 Suppl 2():11-4. PubMed ID: 16974122
[No Abstract] [Full Text] [Related]
7. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
Chien CR; Lai MS
Am J Med Qual; 2006; 21(6):408-14. PubMed ID: 17077423
[TBL] [Abstract][Full Text] [Related]
8. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
[No Abstract] [Full Text] [Related]
10. Managing patients with lung cancer. Guidelines must help bring us in line with European standards.
O'Brien ME; Cullen M
BMJ; 2000 Jun; 320(7249):1604-5. PubMed ID: 10896440
[No Abstract] [Full Text] [Related]
11. Practice guidelines for non-small cell lung cancer.
Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
[No Abstract] [Full Text] [Related]
12. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
13. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
14. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Goss G; Paszat L; Newman TE; Evans WK; Browman G
Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
[TBL] [Abstract][Full Text] [Related]
15. [Guideline on 'non-small cell lung carcinoma; staging and treatment'].
van Meerbeeck JP; Koning CC; Tjan-Heijnen VC; Boekema AG; Kaandorp CJ; Burgers JS
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):72-7. PubMed ID: 15688837
[TBL] [Abstract][Full Text] [Related]
16. [Guide line for the treatment of stage I and stage II non small cell lung cancer].
Kobayashi K
Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):392-403. PubMed ID: 15303438
[TBL] [Abstract][Full Text] [Related]
17. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
[TBL] [Abstract][Full Text] [Related]
18. [Early staging in non-small cell lung cancer].
Eberhardt W; Griesinger F; Filipits M; Winter H
Onkologie; 2012; 35 Suppl 3():6-9. PubMed ID: 22678018
[No Abstract] [Full Text] [Related]
19. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
20. Population variations in the initial treatment of non-small-cell lung cancer.
Potosky AL; Saxman S; Wallace RB; Lynch CF
J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
